Rho Capital Partners’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	–	–	4
2022 Q3	–	Hold	0	–	–	–	4
2022 Q2	–	Sell	-31,858	Closed	-$3M	–	4
2022 Q1	$3.18M	Hold	31,858	–	–	2.2%	3
2021 Q4	$4.95M	Hold	31,858	–	–	3.22%	3
2021 Q3	$7.51M	Hold	31,858	–	–	4.19%	4
2021 Q2	$10.8M	Hold	31,858	–	–	0.99%	6
2021 Q1	$12.9M	Hold	31,858	–	–	1.24%	6
2020 Q4	$21.2M	Hold	31,858	–	–	11.15%	3
2020 Q3	$14.8M	Hold	31,858	–	–	12.35%	3
2020 Q2	$18.6M	Hold	31,858	–	–	12.07%	3
2020 Q1	$4.64M	Hold	31,858	–	–	4.68%	4
2019 Q4	$4.56M	Hold	31,858	–	–	3.47%	4
2019 Q3	$1.26M	Hold	31,858	–	–	1.05%	4
2019 Q2	$3.23M	Hold	31,858	–	–	2.24%	4
2019 Q1	$4.19M	Hold	31,858	–	–	4.43%	3
2018 Q4	$3.25M	Hold	31,858	–	–	4.77%	3
2018 Q3	$7.96M	Hold	31,858	–	–	7.33%	3
2018 Q2	$14.2M	Hold	31,858	–	–	13.61%	3
2018 Q1	$12.6M	Sell	31,858 -863	-3%	-$341K	17.71%	3
2017 Q4	$13.4M	Hold	32,721	–	–	23.36%	2
2017 Q3	$14.1M	Hold	32,721	–	–	22.27%	2
2017 Q2	$11.4M	Buy	+32,721	New	+$11.3M	15.96%	2